Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors

Environmental and Molecular Mutagenesis

Volumn 39, Issue 2-3, 2002, Pages 235-244

  Jeffy, Brandon D ^a   Chirnomas, Ryan B ^a   Romagnolo, Donato F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aromatic hydrocarbon receptor; BRCA 1; Estrogen receptor; p53; Polycyclic aromatic hydrocarbons

Indexed keywords

ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; BRCA1 PROTEIN; ESTROGEN RECEPTOR; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PROTEIN P53; VIRUS PROTEIN; XENOBIOTIC AGENT;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER RISK; CARCINOGENICITY; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DNA DAMAGE; DRUG EFFECT; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LABORATORY; POLLUTANT; PUBLICATION;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BENZO(A)PYRENE; BENZOFLAVONES; BLOTTING, WESTERN; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOGENS; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

PAPILLOMAVIRUS;

EID: 0036202783     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10051     Document Type: Conference Paper

References (63)

1. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents
2. Tumor suppressor p53 is required to modulate BRCA1 expression
3. Identifying human cells capable of metabolizing various classes of carcinogens
4. Identification of benzo[a]pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences
5. Disruption of transcription in vitro and gene expression in vivo by DNA adducts derived from a benzo[a]pyrene diol epoxide located in heterologous sequences
6. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
7. Roles of BRCA1 and its interacting proteins
8. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53
9. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens
10. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB-231 cells
11. BRCA1 mutations in primary breast and ovarian carcinomas
12. α-Naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor
13. BRCA1 required for transcription-coupled repair of oxidative DNA damage
14. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
15. Hormone-dependent regulation of BRCA1 in human breast cancer cells
16. Benzo-a-pyrene. Environmental partitioning and human exposure
17. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin
18. Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa lclc7 cells
19. Growth retardation and tumor inhibition by BRCA1
20. Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: Characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator
21. Inhibition of BRCA-1 expression by benzo[a]pyrene and its diol epoxide
22. Disruption of cell cycle kinetics by benzo[a]pyrene: Inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2
23. Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: Requirements for metabolism of benzo[a]pyrene to BPDE
24. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study
25. Cellular response to DNA damage from a potent carcinogen involves stabilization of p53 without induction of p21(waf1/cip1)
26. DNA adduct levels associated with p53 induction and delay of MCF-7 cells in S phase after exposure to benzo[g]chrysene dihydrodiol epoxide enantiomers
27. Cancer-susceptibility genes: Gatekeepers and caretakers
28. Molecular mechanism of inhibition of estrogen-induced cathepsin-D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 Cells
29. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells
30. The formation and occurrence of polynuclear aromatic hydrocarbons associated with food
31. Repression of BRCA-1 through a feedback loop involving p53
32. Binding of the transcription factor Sp1 to non-target sites in DNA modified by benzo[a]pyrene diol epoxide
33. BRCA1 expression is not directly responsive to estrogen
34. The mechanism of action of α-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression
35. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein
36. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
37. Environmental factors as regulators and effectors of multistep carcinogenesis
38. Benzo[a]pyrene-resistant MCF-7 human breast cancer cells: A unique aryl hydrocarbon-nonresponsive clone
39. Cellular responses to oxidative stress: The [Ah] gene battery as a paradigm
40. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
41. The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons
42. Differential mutagenicity and cytotoxicity of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol and (+/-)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide in genetically engineered human fibroblasts
43. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial cells
44. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts
45. Regulation of subcellular localization of the aryl hydrocarbon receptor (AhR)
46. Estrogen upregulation of expression of BRCA-1 with no effect on localization
47. Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide
48. Molecular biology of the Ah receptor and its role in carcinogenesis
49. Chlorinated hydrocarbons: Estrogens and antiestrogens
50. Development of selective aryl hydrocarbon receptor modulators (SAhRMs) for treatment of breast cancer
51. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons
52. Dynamic changes of BRCA1 subnuclear localization and phosphorylation state are initiated by DNA damage
53. Cell cycle control, checkpoint mechanisms, and genotoxic stress
54. Embyonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2
55. BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers
56. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPI
57. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
58. Characterization of DNA adducts formed by the four configurationally isomeric 5,6-dimethylchrysene 1,2-dihydrodiol 3,4-epoxides
59. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage
60. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
61. Benzo[a]pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer
62. Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene